RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. - Wikidata - awgldk - TriplyDB

RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.

RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.

http://www.wikidata.org/entity/Q37146417

about

Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease The missing link: does tunnelling nanotube-based supercellularity provide a new understanding of chronic and lifestyle diseases?Targeting Reactive Carbonyl Species with Natural Sequestering Agents Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular Disease NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species Redox implications in adipose tissue (dys)function--A new look at old acquaintances Alteration of energy substrates and ROS production in diabetic cardiomyopathy Pericytes, an overlooked player in vascular pathobiology Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy Mitochondrial dysfunction in diabetic cardiomyopathy Mitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stress Dangers within: DAMP responses to damage and cell death in kidney disease.Advanced glycation end products promote the proliferation and migration of primary rat vascular smooth muscle cells via the upregulation of BAG3.Dietary Metabolites and Chronic Kidney Disease.Effect of the age cross-link breaker alagebrium on anterior segment physiology, morphology, and ocular age and rage.Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease.Exercise and Glycemic Control: Focus on Redox Homeostasis and Redox-Sensitive Protein Signaling.AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease.Molecular Pathways Involved in the Amelioration of Myocardial Injury in Diabetic Rats by Kaempferol.Detection of autoantibodies against reactive oxygen species modified glutamic acid decarboxylase-65 in type 1 diabetes associated complications S100A12 mediates aortic wall remodeling and aortic aneurysm.Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial.Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy Prevention of diabetic nephropathy in Ins2(+/)⁻(AkitaJ) mice by the mitochondria-targeted therapy MitoQ.Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update p66Shc mediates high-glucose and angiotensin II-induced oxidative stress renal tubular injury via mitochondrial-dependent apoptotic pathway.Selective macrophage ascorbate deficiency suppresses early atherosclerosis.The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease.Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy.Dietary fat quantity and quality modifies advanced glycation end products metabolism in patients with metabolic syndrome.Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney Increased protein aggregation in Zucker diabetic fatty rat brain: identification of key mechanistic targets and the therapeutic application of hydrogen sulfide.Aldose reductase and AGE-RAGE pathways: central roles in the pathogenesis of vascular dysfunction in aging rats.Regulation of cell transformation by Rb-controlled redox homeostasis.Upstream regulators and downstream effectors of NADPH oxidases as novel therapeutic targets for diabetic kidney disease.

P2860

Q26741451-6B941E68-918A-4078-AE48-669C99CB58D1 Q26747455-3AD61038-7917-4C42-86E3-74A05FDB4A5F Q26765482-014DEB0A-C31F-480C-889A-B932E54352EB Q26773988-407667ED-09E4-4D33-8B6E-E884F1947C9C Q26778527-7CC2CB27-F1EC-425D-BD8E-B30FF592E67A Q26782422-800A4F0B-F12F-45DB-9791-9D13A1CB7343 Q26784322-9C3F1572-A130-4A7C-B3EF-9A51CC7248D6 Q26801347-F97BA41A-7035-4A87-A597-BB75F9F426D8 Q27014882-FBC514F5-0A28-4E7F-BC57-AD062805B819 Q28070053-F1556D3C-B059-4918-8C4E-C4C312B8B026 Q28073661-EC5ACE9F-B71F-4154-B7D8-2F86E963E5B6 Q28083205-DEC8C75F-F524-4238-93E0-2248AE8015FD Q28390863-5551F543-94F7-4AD9-8689-DFC8036C5EE6 Q28660732-02CDEF89-9A9A-4395-8E97-0065BB934CE8 Q30380000-45874F42-755E-4D1A-BB20-CDA614C19299 Q33597584-A4152FFC-CE42-40CC-B4F9-780594415B6B Q33616732-6AF853DD-D6F2-4AED-A5F6-99D5D279F736 Q33623472-34CADF4E-091D-4BA0-9229-DC0C35E4C839 Q33633674-C76A695C-6850-4DFD-9AD0-F4BC9DD6EAC6 Q33639120-7DE35F80-C136-4250-AEC6-C07B5513FE03 Q33727690-0347F106-51AD-4707-99A1-B46949FD15B7 Q33755103-9DB273B6-874F-4618-B09F-212AF3115820 Q33840246-CEEB5E11-075D-41A2-990B-88D9BE8AB674 Q33883852-A1D67170-23FE-4541-8955-FDAEFCF71B25 Q33904838-45F5C749-656D-4231-98AF-41463B87651A Q34067504-D61DE9EB-64A6-4EAD-9A3B-7DEE8F4351BF Q34277437-5D9C38AC-7D69-42FF-98A0-837E4BFD66CD Q34286094-637EC089-D374-44D9-9A76-AD4B2D677E53 Q34305490-CFCDDF16-661F-4540-80B6-E5ECA825D41F Q34459166-5DCC5CE3-80B4-4557-84E7-7A7DCBC413A1 Q34524690-25A029FD-C42A-42B3-A32E-FBF9665219FE Q34550600-99568932-40F1-482B-BAD6-62ADA15AA12C Q34631886-4324D6C1-B911-43EC-ADC6-18B0055E6974 Q34680886-B92543A9-7D48-4CBE-ABBB-8F5980B52F2C Q34836376-E2EA12D7-2D5F-4830-878C-747EAF36F590 Q35026645-E43D12CA-BE81-44D0-B85E-FE7FE2E19163 Q35083908-BA4F12B1-019C-4E19-B9FB-882B9DCBC2F8 Q35090344-FFE312B3-7F84-45D0-86BF-43B5884B804D Q35206258-AE1F7E20-A26E-4AB2-AABF-4D2D710E8405 Q35450699-A5AACB83-7E12-4DAD-B47C-7B53C22593F6

P2860

RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.

http://www.wikidata.org/entity/Q37146417

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.

@en

RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.

@nl

type

label

RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.

@en

RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.

@nl

prefLabel

RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.

@en

RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.

@nl

P1433

Q37146417-3EE96B22-4DAD-46D3-9CF7-758FED971333

P1476

Q37146417-9515F310-FD54-42E7-B4B6-678C3DD86BF4

P2093

Q37146417-01224B75-A78B-43CC-BB67-ACBE907CF062

Q37146417-076C0855-8D14-4E13-93A3-057C1F01CE72

Q37146417-12C9FFCE-51E2-4DD4-ACAC-CF194B2AC491

Q37146417-232474F9-0ECC-4A30-8310-2443DE381B0B

Q37146417-2CF11D6A-A219-483D-9819-8F6802CF6111

Q37146417-37BA88A8-F569-45D7-B32B-21D7D85C968E

Q37146417-3CAA0B6C-C9E7-4CB7-AA45-BB6B409B1020

Q37146417-58E723C0-3116-4488-964F-65AA3AA6258C

Q37146417-6D69C2D4-E737-4B64-8178-4C8CFBE72F8D

Q37146417-8454DDFE-9FF9-4832-8066-07801A11BECC

P2860

Q37146417-0D601E3A-F17B-4CA9-8355-0B247ED0F220

Q37146417-14C0CD44-BFFA-419D-AFF6-B9E9A50F3B71

Q37146417-1552FBAF-73BF-42DA-B3BB-57C07D503198

Q37146417-1AD8B86D-83CE-414E-8591-06F99E3F7423

Q37146417-2635EDF8-4EB0-4823-8882-29B7147A8658

Q37146417-2655ABA2-7A40-4B09-ACD6-E2654D20ED87

Q37146417-2B9BD9F1-FDBC-4E86-9604-0CD2E17817E7

Q37146417-3DC94B71-1232-467F-8EDF-18A0CA7154C9

Q37146417-425B03EC-5D88-4C97-AE90-289735C1C9EE

Q37146417-48147804-4CF0-4614-A049-3A47F8C310D0

P304

Q37146417-1AFC6EE4-3CAF-4F21-B3BF-B00FA50E6225

P31

Q37146417-3EBE557D-6AB0-44A2-8887-F1C9D53B3C28

P356

Q37146417-1854DABE-92D4-417F-9C6A-D070FDA8BA81

P433

Q37146417-B8485772-F473-4DBE-8557-4800B0EEB308

P478

Q37146417-553A32C0-B255-441A-9FD1-0A026F6A6762

P50

Q37146417-A3F24B18-157B-44D9-89DB-E58A7E7B845D

Q37146417-AD1018BC-45AA-42C0-AE7B-8B379A43D8A9

Q37146417-D924BBB5-D375-4352-B76A-D4FC0E677604

P577

Q37146417-601466F2-32E2-4892-9788-373BBFCD46B7

P698

Q37146417-7C84645B-EA78-4B38-9CBA-DDC736E79C6C

P921

Q37146417-6EF4E952-8557-4F0F-B12E-7546894A2F84

P932

Q37146417-1E7CC68A-2E98-4434-B98B-6B932286D5F4

P356

P1433

Journal of the American Society of Nephrology

P1476

RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes

@en

P2093

Adeline L Y Tan

http://www.w3.org/2001/XMLSchema#string

Adrienne Laskowski

http://www.w3.org/2001/XMLSchema#string

Angelika Bierhaus

http://www.w3.org/2001/XMLSchema#string

Karly C Sourris

http://www.w3.org/2001/XMLSchema#string

Kei Fukami

http://www.w3.org/2001/XMLSchema#string

Mark E Cooper

http://www.w3.org/2001/XMLSchema#string

Melinda T Coughlan

http://www.w3.org/2001/XMLSchema#string

Michael Brownlee

http://www.w3.org/2001/XMLSchema#string

Peter P Nawroth

http://www.w3.org/2001/XMLSchema#string

Sally A Penfold

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c

Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily

Biochemistry and molecular cell biology of diabetic complications

Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor

An analysis of the role of coenzyme Q in free radical generation and as an antioxidant.

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

P304

742-752

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2008050514

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Josephine M. Forbes

Brooke E Harcourt

P577

2009-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19158353

http://www.w3.org/2001/XMLSchema#string

P921

P932

2663823

http://www.w3.org/2001/XMLSchema#string